KYNTRA BIO INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$4.57
-1.72%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-29.7%
3 months
-32.4%
6 months
-35.5%
1 year
-58.6%
Year to date
-48.0%
52-week range
$4.50 – $11.12
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$18.5M
P/E
0.1
P/B
-0.6
P/S
4
Revenue
$4.62M
Net income
$183.19M
Diluted EPS
45.28
Gross margin
6.30%
Net margin
3967.80%
Return on equity
-605.50%
Total debt
$70.5M
Cash
$50.64M
Free cash flow
-$38.06M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | -$1.47M | $11.97M | 100.10% | -812.30% | -$3.99M |
| Mar 31, 2026 | $3.74M | -$15.2M | -9.80% | -406.60% | -$13.89M |
| Dec 31, 2025 | $1.28M | -$14.22M | 78.20% | -1113.50% | -$18.33M |
| Sep 30, 2025 | $1.08M | $200.64M | 105.40% | 18646.50% | -$1.86M |
| Jun 30, 2025 | $1.35M | -$7.6M | 93.70% | -564.00% | $12.67M |
| Mar 31, 2025 | $2.74M | $4.64M | 90.80% | 169.40% | $2.7M |
| Dec 31, 2024 | -$123.26M | $17.98M | 83.20% | -14.60% | -$30.4M |
| Sep 30, 2024 | $46.33M | -$17.08M | 88.60% | -36.90% | -$7.62M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent KYNB news
All market newsNo ticker-linked stories are in the current archive.